173 related articles for article (PubMed ID: 26361828)
1. Interplay Between Adiponectin and Pro-Atrial Natriuretic Peptide and Prognosis in Patients With ST-Segment Elevation Myocardial Infarction.
Lindberg S; Jensen JS; Hoffmann S; Pedersen SH; Iversen AZ; Galatius S; Frystyk J; Flyvbjerg A; Goetze JP; Bjerre M; Mogelvang R
Am J Cardiol; 2015 Nov; 116(9):1340-5. PubMed ID: 26361828
[TBL] [Abstract][Full Text] [Related]
2. MR-proANP improves prediction of mortality and cardiovascular events in patients with STEMI.
Lindberg S; Jensen JS; Pedersen SH; Galatius S; Goetze JP; Mogelvang R
Eur J Prev Cardiol; 2015 Jun; 22(6):693-700. PubMed ID: 24906365
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of adiponectin as a predictor of all cause mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Lindberg S; Pedersen SH; Møgelvang R; Bjerre M; Frystyk J; Flyvbjerg A; Galatius S; Jensen JS
Am J Cardiol; 2012 Feb; 109(4):492-6. PubMed ID: 22105783
[TBL] [Abstract][Full Text] [Related]
4. Soluble form of membrane attack complex independently predicts mortality and cardiovascular events in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
Lindberg S; Pedersen SH; Mogelvang R; Galatius S; Flyvbjerg A; Jensen JS; Bjerre M
Am Heart J; 2012 Nov; 164(5):786-92. PubMed ID: 23137511
[TBL] [Abstract][Full Text] [Related]
5. Prognostic utility of neutrophil gelatinase-associated lipocalin in predicting mortality and cardiovascular events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Lindberg S; Pedersen SH; Mogelvang R; Jensen JS; Flyvbjerg A; Galatius S; Magnusson NE
J Am Coll Cardiol; 2012 Jul; 60(4):339-45. PubMed ID: 22813613
[TBL] [Abstract][Full Text] [Related]
6. Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
Khan SQ; Dhillon O; Kelly D; Squire IB; Struck J; Quinn P; Morgenthaler NG; Bergmann A; Davies JE; Ng LL
J Am Coll Cardiol; 2008 May; 51(19):1857-64. PubMed ID: 18466800
[TBL] [Abstract][Full Text] [Related]
7. Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
Seo SM; Kim S; Chang K; Min J; Kim TH; Koh YS; Park HJ; Shin WS; Lee JM; Kim PJ; Chung WS; Seung KB
Coron Artery Dis; 2011; 22(6):405-10. PubMed ID: 21701385
[TBL] [Abstract][Full Text] [Related]
8. Time to treatment and three-year mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction-a DANish Trial in Acute Myocardial Infarction-2 (DANAMI-2) substudy.
Maeng M; Nielsen PH; Busk M; Mortensen LS; Kristensen SD; Nielsen TT; Andersen HR;
Am J Cardiol; 2010 Jun; 105(11):1528-34. PubMed ID: 20494656
[TBL] [Abstract][Full Text] [Related]
9. Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36).
O'Malley RG; Bonaca MP; Scirica BM; Murphy SA; Jarolim P; Sabatine MS; Braunwald E; Morrow DA
J Am Coll Cardiol; 2014 Apr; 63(16):1644-53. PubMed ID: 24530676
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of B-type natriuretic peptide levels on admission in patients with acute ST elevation myocardial infarction.
Grabowski M; Filipiak KJ; Karpinski G; Wretowski D; Rdzanek A; Rudzki D; Główczyńska R; Rudowski R; Opolski G
Acta Cardiol; 2005 Oct; 60(5):537-42. PubMed ID: 16261786
[TBL] [Abstract][Full Text] [Related]
11. Risk assessment in patients with unstable angina/non-ST-elevation myocardial infarction and normal N-terminal pro-brain natriuretic peptide levels by N-terminal pro-atrial natriuretic peptide.
Jarai R; Iordanova N; Jarai R; Raffetseder A; Woloszczuk W; Gyöngyösi M; Geyer G; Wojta J; Huber K
Eur Heart J; 2005 Feb; 26(3):250-6. PubMed ID: 15618049
[TBL] [Abstract][Full Text] [Related]
12. Value of blood adipose tissue hormones concentration--adiponectin, resistin and leptin in the prediction of major adverse cardiac events (MACE) in 1-year follow-up after primary percutaneous coronary intervention in ST-segment elevation acute myocardial infarction.
Piestrzeniewicz K; Luczak K; Goch JH
Neuro Endocrinol Lett; 2008 Aug; 29(4):581-8. PubMed ID: 18766137
[TBL] [Abstract][Full Text] [Related]
13. The impact of distal embolization and distal protection on long-term outcome in patients with ST elevation myocardial infarction randomized to primary percutaneous coronary intervention--results from a randomized study.
Lønborg J; Kelbæk H; Helqvist S; Holmvang L; Jørgensen E; Saunamäki K; Kløvgaard L; Kaltoft A; Bøtker HE; Lassen JF; Thuesen L; Terkelsen CJ; Kofoed KF; Clemmensen P; Køber L; Engstrøm T
Eur Heart J Acute Cardiovasc Care; 2015 Apr; 4(2):180-8. PubMed ID: 25013089
[TBL] [Abstract][Full Text] [Related]
14. Hematocrit level as a marker of outcome in ST-segment elevation myocardial infarction.
Greenberg G; Assali A; Vaknin-Assa H; Brosh D; Teplitsky I; Fuchs S; Battler A; Kornowski R; Lev EI
Am J Cardiol; 2010 Feb; 105(4):435-40. PubMed ID: 20152235
[TBL] [Abstract][Full Text] [Related]
15. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.
Akpek M; Kaya MG; Lam YY; Sahin O; Elcik D; Celik T; Ergin A; Gibson CM
Am J Cardiol; 2012 Sep; 110(5):621-7. PubMed ID: 22608360
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Serum Uric Acid, Bilirubin, and C-Reactive Protein as Prognostic Biomarkers of In-Hospital MACE Between Women and Men With ST-Segment Elevation Myocardial Infarction.
Baumann S; Huseynov A; Koepp J; Jabbour C; Behnes M; Becher T; Renker M; Lang S; Borggrefe M; Lehmann R; Akin I
Angiology; 2016 Mar; 67(3):272-80. PubMed ID: 26032849
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of ST resolution analysis performed immediately versus at ninety minutes after primary percutaneous coronary intervention.
Kumar S; Sivagangabalan G; Hsieh C; Ryding AD; Narayan A; Chan H; Burgess DC; Ong AT; Sadick N; Kovoor P
Am J Cardiol; 2010 Feb; 105(4):467-74. PubMed ID: 20152240
[TBL] [Abstract][Full Text] [Related]
18. Cardio-adipose tissue cross-talk: relationship between adiponectin, plasma pro brain natriuretic peptide and incident heart failure.
Lindberg S; Jensen JS; Bjerre M; Pedersen SH; Frystyk J; Flyvbjerg A; Mogelvang R
Eur J Heart Fail; 2014 Jun; 16(6):633-8. PubMed ID: 24723498
[TBL] [Abstract][Full Text] [Related]
19. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
[TBL] [Abstract][Full Text] [Related]
20. [Effects of hemoglobin levels on long-term prognosis in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
Wang CH; Jin XF; Fang Q; Zhang SY; Shen ZJ; Fan ZJ; Liu ZY; Xie HZ
Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(42):3003-6. PubMed ID: 22333029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
